Changing Neoadjuvant and Adjuvant Paradigms in HER2-Positive Breast Cancer: What Surgeons Need to Know

ESSO, Medscape
Europe/Paris GMT+2

Description

PROGRAM Friday, 16 October 2020

12:30

Introduction

Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil.

12:34

The Changing Paradigm in Neoadjuvant/Adjuvant: What Is the Evidence?

Christian Jackisch, MD, PhD

12:46

Neoadjuvant or Not? What Is the Best Practice?

Fabien Reyal, MD, PhD

12:58

Assessment of Pathologic Complete Response and Residual Disease: What Is the State of the Art?

Michael Knauer, MD, PhD, FEBS

13:10

Putting It Together in Practice: What Does It All Mean for Surgeons?

Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil. and Faculty Panel

13:28

So, What Do Surgeons Need to Know?

Tibor Kovacs, PhD, FRCS, FEBS, Med. Habil.

Tibor Kovacs

Introduction, The Changing Paradigm in Neoadjuvant/Adjuvant: What Is the Evidence?, Neoadjuvant or Not? What Is the Best Practice?, Assessment of Pathologic Complete Response and Residual Disease: What Is the State of the Art?, Putting It Together in Practice: What Does It All Mean for Surgeons? So, What Do Surgeons Need to Know?

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Christian Jackisch, Michael Knauer, Fabien Reyal

 

Link to the Event

Banner to the Event

Changing Neoadjuvant and Adjuvant Paradigms in HER2-Positive Breast Cancer: What Surgeons Need to Know
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"